DOI: 10.1055/s-0040-1713152
Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research
Authors
-
Behnood Bikdeli *
1 New York-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, United States2 Center for Outcomes Research and Evaluation (CORE), Yale School of Medicine, New Haven, Connecticut, United States3 Clinical Trials Center, Cardiovascular Research Foundation, New York, New York, United States -
Mahesh V. Madhavan‡ *
1 New York-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, United States3 Clinical Trials Center, Cardiovascular Research Foundation, New York, New York, United States -
Aakriti Gupta
1 New York-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, United States2 Center for Outcomes Research and Evaluation (CORE), Yale School of Medicine, New Haven, Connecticut, United States3 Clinical Trials Center, Cardiovascular Research Foundation, New York, New York, United States -
David Jimenez
4 Respiratory Department, Hospital Ramón y Cajal, Madrid, Spain5 Medicine Department, Universidad de Alcalá (IRYCIS), CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain -
John R. Burton
1 New York-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, United States -
Caroline Der Nigoghossian
1 New York-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, United States -
Taylor Chuich
1 New York-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, United States -
Shayan Nabavi Nouri
1 New York-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, United States -
Isaac Dreyfus
1 New York-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, United States -
Elissa Driggin
1 New York-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, United States -
Sanjum Sethi
1 New York-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, United States -
Kartik Sehgal
6 Harvard Medical School, Boston, Massachusetts, United States7 Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States -
Saurav Chatterjee
8 North Shore and Long Island Jewish University Hospitals, Queens, New York, United States -
Walter Ageno
9 Department of Medicine and Surgery, University of Insubria, Varese, Italy -
Mohammad Madjid
10 McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, United States -
11 Department of Cardiology, Chinese PLA General Hospital, Beijing, China12 Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart and Chest Hospital, Liverpool, United Kingdom
-
Liang V. Tang
13 Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China -
Yu Hu
13 Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China -
14 Department of “Médecine Vasculaire et Thérapeutique,” CIC 1408, INNOVTE, CHU de St-Etienne and INSERM UMR1059, Université Jean-Monnet, Saint-Etienne, France
-
Jay Giri
15 Cardiovascular Division, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States16 Penn Cardiovascular Outcomes, Quality, and Evaluative Research Center, Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania, United States17 Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania, United States -
Mary Cushman
18 Larner College of Medicine, University of Vermont, Burlington, Vermont, United States -
Isabelle Quéré
19 Department of Vascular Medicine, University of Montpellier, Montpellier CHU, InnoVTE F-CRIN Network, Montpellier, France -
Evangelos P. Dimakakos
20 Oncology Unit GPP, Sotiria General Hospital, Athens School of Medicine, Athens, Greece -
C. Michael Gibson
6 Harvard Medical School, Boston, Massachusetts, United States7 Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States -
Giuseppe Lippi
21 Laboratory of Clinical Chemistry and Hematology, University Hospital of Verona, Verona, Italy -
Emmanuel J. Favaloro
22 Laboratory Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), NSW Health Pathology, Westmead Hospital, Westmead, NSW, Australia23 Sydney Centres for Thrombosis and Haemostasis, Westmead, NSW, Australia -
Jawed Fareed
24 Loyola University Medical Center, Chicago, Illinois, United States -
Alfonso J. Tafur
25 Pritzker School of Medicine at the University of Chicago, Chicago, Illinois, United States26 Division of Vascular Medicine, Department of Medicine, NorthShore University HealthSystem, Skokie, Illinois, United States -
Dominic P. Francese
3 Clinical Trials Center, Cardiovascular Research Foundation, New York, New York, United States -
Jaya Batra
1 New York-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, United States -
Anna Falanga
27 Department of Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, University of Milan Bicocca, Bergamo, Italy -
Kevin J. Clerkin
1 New York-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, United States -
Nir Uriel
1 New York-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, United States -
Ajay Kirtane
1 New York-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, United States3 Clinical Trials Center, Cardiovascular Research Foundation, New York, New York, United States -
Claire McLintock
28 Auckland City Hospital, Auckland, New Zealand -
Beverley J. Hunt
29 St Thomas' Hospital, London, United Kingdom -
Alex C. Spyropoulos
30 The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New York, New York, United States -
Geoffrey D. Barnes
31 Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan, United States32 Frankel Cardiovascular Center, University of Michigan, Ann Arbor, Michigan, United States -
John W. Eikelboom
33 Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada -
Ido Weinberg
6 Harvard Medical School, Boston, Massachusetts, United States34 Massachusetts General Hospital, Boston, Massachusetts, United States -
Sam Schulman
35 Department of Obstetrics and Gynecology, I.M. Sechenov First Moscow State Medical University, Moscow, Russia36 McMaster University, Hamilton, Ontario, Canada37 Thrombosis & Atherosclerosis Research Institute, Hamilton, Ontario, Canada -
Marc Carrier
38 The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada -
Gregory Piazza
6 Harvard Medical School, Boston, Massachusetts, United States39 Brigham and Women's Hospital, Boston, Massachusetts, United States -
Joshua A. Beckman
40 Vanderbilt University School of Medicine, Nashville, Tennessee, United States -
Martin B. Leon
1 New York-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, United States3 Clinical Trials Center, Cardiovascular Research Foundation, New York, New York, United States -
Gregg W. Stone
3 Clinical Trials Center, Cardiovascular Research Foundation, New York, New York, United States41 The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States -
Stephan Rosenkranz
42 Department of Cardiology, Cologne Cardiovascular Research Center (CCRC), Heart Center at the University of Cologne, University of Cologne, Cologne, Germany -
Samuel Z. Goldhaber
6 Harvard Medical School, Boston, Massachusetts, United States39 Brigham and Women's Hospital, Boston, Massachusetts, United States -
Sahil A. Parikh
1 New York-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, United States3 Clinical Trials Center, Cardiovascular Research Foundation, New York, New York, United States -
Manuel Monreal
43 Department of Internal Medicine, Hospital Universitari Germans Trials I Pujol, Universidad Católica de Murcia, Barcelona, Spain -
Harlan M. Krumholz
2 Center for Outcomes Research and Evaluation (CORE), Yale School of Medicine, New Haven, Connecticut, United States44 Department of Health Policy and Administration, Yale School of Public Health, New Haven, Connecticut, United States45 Section of Cardiovascular Medicine, Department of Internal Medicie, Yale School of Medicine, New Haven, Connecticut, United States -
46 Center for Thrombosis and Hemostasis, Johannes Gutenberg University of Mainz, Mainz, Germany
-
Jeffrey I. Weitz
36 McMaster University, Hamilton, Ontario, Canada37 Thrombosis & Atherosclerosis Research Institute, Hamilton, Ontario, Canada -
12 Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart and Chest Hospital, Liverpool, United Kingdom47 Department of Clinical Medicine, Aalborg Thrombosis Research Unit, Aalborg University, Aalborg, Denmark
